Thank you, Chair.
I want to ask Mr. Smardon a couple of questions.
First of all, I liked your presentation because it focuses on a key step whereby you move research that we develop in labs to the market. It's unfortunately a high-risk endeavour. In fact, this is where venture capitalism comes in—people who are willing to take a lot of risk, because for every 100 products that look really good, a small number actually become successfully marketed to consumers or to industries and eventually to consumers.
Could you comment, first of all, on this risk? I'll call it a high level of risk.
The second thing is, could you comment on whether you think the government should be involved during this transition stage, if the risk is so high?
Perhaps the third question I'll ask is, what would you propose as risk mitigation strategies, in other words things that would actually lower the risk? Is it possible to lower the risk?